The aim of this study is to compare HCC recurrence-free survival probabilities in a low AFP population with low or high PIVKA-II levels stratified according to low or high RETREAT scores and whether PIVKA-II can be used as a predictor for explant microvascular invasion. This evidence concerns the gene AFP and hepatocellular carcinoma.